Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
Ionizing radiation (IR) and chemotherapy are standard-of-care treatments for glioblastoma (GBM) patients and both result in DNA damage, however, the clinical efficacy is limited due to therapeutic resistance. We identified a mechanism of such resistance mediated by phosphorylation of PTEN on tyrosin...
Saved in:
Published in | Cancer cell Vol. 35; no. 3; pp. 504 - 518.e7 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
18.03.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Ionizing radiation (IR) and chemotherapy are standard-of-care treatments for glioblastoma (GBM) patients and both result in DNA damage, however, the clinical efficacy is limited due to therapeutic resistance. We identified a mechanism of such resistance mediated by phosphorylation of PTEN on tyrosine 240 (pY240-PTEN) by FGFR2. pY240-PTEN is rapidly elevated and bound to chromatin through interaction with Ki-67 in response to IR treatment and facilitates the recruitment of RAD51 to promote DNA repair. Blocking Y240 phosphorylation confers radiation sensitivity to tumors and extends survival in GBM preclinical models. Y240F-Pten knockin mice showed radiation sensitivity. These results suggest that FGFR-mediated pY240-PTEN is a key mechanism of radiation resistance and is an actionable target for improving radiotherapy efficacy.
[Display omitted]
•Phosphorylation of PTEN at tyrosine 240 (pY240) by FGFR2 mediates IR resistance•pY240-PTEN plays a critical role in DNA damage repair•pY240-PTEN associates with chromatin DNA through interaction with Ki-67•Blocking pY240-PTEN using FGFR inhibitors sensitizes tumors to ionizing radiation
Ma et al. show that ionizing irradiation (IR) induces PTEN Y240 phosphorylation (pY240-PTEN) by FGFR2 in glioblastoma (GBM) cells. pY240-PTEN binds to chromatin and recruits RAD51 to promote DNA repair. Inhibition of Y240 phosphorylation sensitizes GBM to IR and prolongs the survival of GBM preclinical models. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 J.M., J.B., C.C. and F.B.F., conceived and designed the research; J.M, J.B., J.L. performed in vivo and in vitro experiments and analyzed data; C.P.A. performed SILAC-mass spectrum experiment; T.G. performed the IHC assay using GBM patient samples; L.O. performed the simulation experiments and E.L. and L.O. did the analysis; R.R. engineered Y240F knock-in mice; C.Z. performed in vivo experiments; N.M.V. helped with mouse tissue preparation and staining assessment; T.R.F., R.D.K., S.N.M., E.S., T.G., A.S., H.Z., W.K.C. contributed to the design of experiments and interpretation of data; J.M. and F.B.F wrote the initial manuscript and C.C, F.B.F, H. Z., M.A., R.D.K and W.K.C. revised the manuscript. AUTHOR CONTRIBUTIONS |
ISSN: | 1535-6108 1878-3686 1878-3686 |
DOI: | 10.1016/j.ccell.2019.01.020 |